Skip to main content

Table 1 Standards of care for the management of diabetes according to the recommendations from the International Diabetes Federation

From: Sex differences in the risk of vascular disease associated with diabetes

Standards of care for the management of diabetes by the International Diabetes Federation [3, 45]
Risk factor screeningLifestyle and educationDrug interventions and target values
Clinical assessment:
- Weight, BMI, waist circumference, blood pressure, screening for retinopathy (every 1 to 2 years) and peripheral neuropathy, feet exam (every year), screening for macrovascular disease (if patient is symptomatic).
Biochemical assessment:
- HbA1c, lipid spectrum, renal function (every year)
Lifestyle assessment:
- Smoking status, overweight, physical activity, diet
Education:
- Referral to diabetes education program
Diet:
- Reduce caloric intake with obesity or overweight, if possible referral to a dietician
- Prefer high fiber and low-glycemic index foods
- Avoidance of sugar, sweets, and sweetened beverages
Physical activity:
- Increase of physical activity
Habits:
- Avoid smoking
- Avoid excess alcohol intake
Start lipid-lowering drugs:
- T2DM and established CVD
- T2DM, no established CVD, ≥ 40 years and LDL cholesterol > 100 mg/dL
- T2DM, no established CVD, LDL cholesterol > 70 mg/dL may benefit especially with high 10-year CVD risk
Start glucose-lowering drugs:
- General HbA1c target < 7%, > 8% is generally unacceptable
- HbA1c levels between 7.5 and 8% may be acceptable for patients using multiple drugs, if expected survival is limited, cognitive impairment CKD or severe CVD associated with multiple comorbidities.
Start antihypertensive drugs:
- Diastolic target 80 mmHg
- Systolic target of 130 to 140 mmHg
Start ACE-inhibitor or ARB:
- Persistent albuminuria
  1. [3,45] CVD cardiovascular disease, BMI body mass index, T2DM type 2 diabetes mellitus, CKD chronic kidney disease, ACE-I angiotensin converting enzyme-inhibitor, ARB angiotensin receptor blocker